Vikas Goyal


vikas.goyal.wg10@wharton.upenn.edu Harvard College, Cambridge, MA A.B. with honors, Neurobiology, 2001


Brandi S. Herman brandi.herman.wg10@wharton.upenn.edu


Bucknell University, Lewisburg, PA B.S., Mathematics, 2002


Andrew M. Hunt II


andrew.hunt.wg10@wharton.upenn.edu Brown University, Providence, RI B.A., Economics and History


To grow entrepreneurial life science companies based on cutting-edge innovation that could transform patient care.


SR One, Conshohocken, PA Intern, 2009-Present


Evaluated new investment opportunities in medication adherence, cancer metabolism, hearing loss, autoimmune and metabolic disease. Developed pitch materials and target lists for spin-out of select secondary manufac- turing and preformulation assets from GlaxoSmithKline.


Extera Partners, Boston, MA Senior Associate and co-Founder, 2004-2008


Launched consulting practice providing interim management, R&D and pipeline planning and business development support to cutting-edge life science companies. Led approximately 50 engagements for angel, venture- backed and small-cap life science firms from the U.S., E.U., Asia and Israel. Established a 200-person Advisory Board of senior executives, clinical thought leaders and industry consultants to support my clients.


McKinsey & Co., Florham Park, NJ Senior Analyst, 2001-2003 Worked with top-tier pharmaceutical, medical device and consumer health companies around the world. Developed marketing plan that doubled sales growth for Indian subsidiary of a global orthopedics player. Evaluated oral care pharmaceuticals market, resulting in $85M acquisition by leading consumer health company. Managed post-merger First-100-Days plan for top animal health company.


An opportunity in finance and strategy in the healthcare industry.


Johnson & Johnson Pharmaceutical Research & Development, Radnor, PA Finance Manager, Summer 2009 Completed financial analysis for restructuring of the J&J pharmaceutical development organization. Designed financial processes for a newly created Biotechnology organization.


Johnson & Johnson Pharmaceutical Research & Development, Raritan, NJ Finance Manager, 2006-2008 Successfully led key Global R&D Business Plan activities, including creating financial targets, calculating restructuring changes & framing the key risks. Provided financial support to 5 board members with total expenses of $320M. Supervised 5 direct reports.


Johnson & Johnson Corporate Internal Audit, New Brunswick, NJ Supervising Senior, Senior Financial Analyst & Financial Analyst, 2004-2006 Managed the ongoing evaluation of internal controls and Sarbanes Oxley 404 compliance for 50+ international pharmaceutical & medical device affiliates with combined annual sales of $7.3B. Supervised 5 direct reports.


Johnson & Johnson Financial Leadership & Development Program, New Brunswick & Raritan, NJ and Milpitas, CA Financial Analyst & Associate Financial Analyst, 2002-2004


Provided budgeting support for pharmaceutical strategic marketing. Consolidated and analyzed monthly manufacturing variances at LifeScan. Attained Six Sigma Green Belt certification.


An opportunity in healthcare focused private equity.


SV Life Sciences, Boston, MA Summer Associate at $2 Billion Healthcare- Focused Venture Capital Firm, Summer 2009 Independently generated, analyzed and pursued healthcare acquisition opportunities. Assisted in structuring, negotiating and valuing live transac- tions and assisted in developing strategy for portfolio companies. Participated in board meetings for US Renal Care, Vitalize, Socios Mayores, Spectrum Professional Services, CRI Worldwide and others. Completed a 10-week, in-depth analysis of investment oppor- tunities in the healthcare information technology and healthcare revenue cycle management spaces and presented actionable thesis to partnership.


Cain Brothers & Co., LLC, New York, NY Investment Banking Analyst, 2005-2008 Pitched and executed up to eight concurrent live transactions on small-deal teams consisting of 2 to 3 bankers across a wide range of trans- action types and healthcare verticals, including health care IT, medical devices and health care services. Constructed valuation analysis, crafted pitch and assisted in executing the $500m acquisition of John Deere Health Care by UnitedHealth Group. Valued and executed 3 private place- ments, including the $9.5m investment in Socios Mayores.


13


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40